Brand name: Geodon
Generic name/category: Ziprasidone, Atypical antipsychotic
Company: Pfizer
Country/Market: USA, North America
Indication(s)/use: acute agitation in schizophrenic patients and acute treatment of mania and mixed states associated with bipolar disorder
Target: Healthcare Professionals (HCP)
Tagline: See me for who I can be
Medium: Print ad
Size/duration: single-page
Publication/Aired: October and November 2009

To see all of this brand’s ads on AdPharm, click here

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.

Click here to see it on AdPharm

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.

Click here to see it on AdPharm

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.

Click on image to view ad details and full-size version on AdPharm

To see all of this brand’s ads on AdPharm, click here

Click on thumbnail to view the full-size ad on AdPharm

Acid reflux disease.
Burning. Bad taste in your throat. Belching.

Try AcipHex free for 2 weeks!
1-800-203-8672
TryAciphex.com/72

Brand name: AcipHex
Generic name/category: Rabeprazole, Prodrugs, Proton pump inhibitors, Benzimidazoles, Sulfoxides
Company: Eisai and PriCara
Country/Market: USA, North America
Indication(s)/use: Acid reflux disease
Target: Consumers (DTC) / Healthcare Professionals (HCP) / Trade
Tagline: Acid reflux disease. It’s got many faces.
Medium: Print ad
Size/duration: single-page
Publication/Aired: Ladies’ Home Journal – October 2009

To see all of this brand’s ads on AdPharm, click here

Control acute agitation with Geodon for injection

In schizophrenia… Rapid improvement with low EPS

Ziprasidone (marketed as Geodon, Zeldox by Pfizer) was the fifth atypical antipsychotic to gain FDA approval (February 2001). In the United States, Ziprasidone is Food and Drug Administration (FDA) approved for the treatment of schizophrenia, and the intramuscular injection form of ziprasidone is approved for acute agitation in schizophrenic patients. Ziprasidone has also received approval for acute treatment of mania and mixed states associated with bipolar disorder. The brand name Geodon has been suggested to bring to mind the phrase 'down (don) to earth (geo)' referring to the goals of the medication.

The oral form of ziprasidone is the hydrochloride salt, ziprasidone hydrochloride. The intramuscular form, on the other hand, is the mesylate salt, ziprasidone mesylate trihydrate, and is provided as a lyophilized powder.

More on Wikipedia

From Wikipedia (text available under Creative Commons Attribution/Share-Alike License)

Brand name: Geodon
Generic name/category: Ziprasidone, Atypical antipsychotics
Company: Pfizer
Country/Market: USA, North America
Indication(s)/use: Schizophrenia
Target: Healthcare Professionals (HCP)
Medium: Print ad
Size/duration single-page
Publication/Aired: American College Of Emergency Physicians – April 2007

To see all of this brand's ads on AdPharm, click here
2 views
Aug 23, 2009

Visit AdPharm.net for more pharmaceutical ads

Now approved for acquired hemophilia
With a life-threatening acquired hemophilia bleed, every minute counts.
Stop it with NovoSeven

For options on how to access NovoSeven, go to accessnovoseven.com or call 1-877-NOVO-777

Recombinant human factor VIIa (NovoSeven, eptacog alfa [activated], ATC code B02BD08) has been introduced for use in uncontrollable bleeding in hemophilia patients (with Factor VIII or IX deficiency) who have developed inhibitors against replacement coagulation factor.

It is being increasingly used in uncontrollable hemorrhage. The first report of its use was in an Israeli soldier with uncontrollable bleeding in 1999. The rationale for its use in hemorrhage is, that it will only induce coagulation in those sites where tissue factor (TF) is also present. Still, O'Connell et al. report an increased risk of deep vein thrombosis, pulmonary embolism and myocardial infarction in association with the use of rhFVIIa.

According to a 2005 study, recombinant human factor VII improves outcomes in acute intracerebral hemorrhage.

More on Wikipedia

From Wikipedia (text available under Creative Commons Attribution/Share-Alike License)

Brand name: NovoSeven
Generic name/category: Eptacog alfa (activated)
Company: Novo Nordisk
Country/Market: USA, North America
Indication(s)/use: uncontrollable hemorrhage, acquired haemophilia
Target: Healthcare Professionals (HCP)
Tagline: Let nothing inhibit their passion
Medium: Print ad
Size/duration single-page
Publication/Aired: American College Of Emergency Physicians – April 2007

To see all of this brand's ads on AdPharm, click here
0 views
Aug 23, 2009

Visit AdPharm.net for more pharmaceutical ads